Cushman Investments vs Sale Purchase Of Stock Analysis

CWK Stock

USD 15.31 0.00 0.00%

Cushman Wakefield financial indicator trend analysis is way more than just evaluating Cushman Wakefield plc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cushman Wakefield plc is a good investment. Please check the relationship between Cushman Wakefield Investments and its Sale Purchase Of Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cushman Wakefield plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Investments vs Sale Purchase Of Stock

Investments vs Sale Purchase Of Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cushman Wakefield plc Investments account and Sale Purchase Of Stock. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Cushman Wakefield's Investments and Sale Purchase Of Stock is 0.1. Overlapping area represents the amount of variation of Investments that can explain the historical movement of Sale Purchase Of Stock in the same time period over historical financial statements of Cushman Wakefield plc, assuming nothing else is changed. The correlation between historical values of Cushman Wakefield's Investments and Sale Purchase Of Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Investments of Cushman Wakefield plc are associated (or correlated) with its Sale Purchase Of Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Sale Purchase Of Stock has no effect on the direction of Investments i.e., Cushman Wakefield's Investments and Sale Purchase Of Stock go up and down completely randomly.

Correlation Coefficient

0.1

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Sale Purchase Of Stock

Most indicators from Cushman Wakefield's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cushman Wakefield plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cushman Wakefield plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

At this time, Cushman Wakefield's Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 0.17 this year, although the value of Tax Provision will most likely fall to about 5.1 M.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	8.8B	9.6B	243.4M	231.2M
Interest Income	158.3M	108.1M	97.3M	126.3M

Depreciation And Amortization Interest Income

Cushman Wakefield fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse
Common Stock Shares Outstanding		0.94	0.95	0.72	0.89	0.82	-0.82	0.74	0.94	0.51	0.83	-0.58	0.87	0.69	0.93	0.94	0.67	0.83	0.69	0.83	0.94	-0.82	0.82	0.81	0.83	0.82
Total Assets	0.94		0.95	0.9	0.96	0.95	-0.92	0.82	0.95	0.24	0.74	-0.66	0.96	0.81	0.95	0.97	0.74	0.87	0.81	0.9	0.97	-0.94	0.93	0.84	0.75	0.94
Short Long Term Debt Total	0.95	0.95		0.85	0.88	0.81	-0.82	0.74	0.9	0.4	0.86	-0.66	0.86	0.75	0.94	0.95	0.71	0.96	0.75	0.85	0.97	-0.83	0.84	0.9	0.89	0.84
Other Current Liab	0.72	0.9	0.85		0.84	0.89	-0.82	0.73	0.77	-0.03	0.62	-0.65	0.86	0.79	0.84	0.87	0.77	0.87	0.79	0.83	0.86	-0.87	0.9	0.84	0.63	0.89
Total Current Liabilities	0.89	0.96	0.88	0.84		0.92	-0.98	0.78	0.94	0.23	0.67	-0.68	0.97	0.77	0.89	0.92	0.68	0.78	0.77	0.88	0.95	-0.92	0.93	0.77	0.6	0.92
Total Stockholder Equity	0.82	0.95	0.81	0.89	0.92		-0.92	0.83	0.91	0.03	0.56	-0.6	0.97	0.79	0.86	0.9	0.77	0.72	0.79	0.86	0.88	-0.95	0.96	0.76	0.53	0.97
Other Liab	-0.82	-0.92	-0.82	-0.82	-0.98	-0.92		-0.76	-0.93	-0.12	-0.58	0.72	-0.97	-0.79	-0.82	-0.86	-0.65	-0.72	-0.79	-0.84	-0.92	0.91	-0.95	-0.74	-0.49	-0.92
Net Tangible Assets	0.74	0.82	0.74	0.73	0.78	0.83	-0.76		0.8	0.15	0.67	-0.25	0.78	0.51	0.84	0.77	0.84	0.72	0.51	0.71	0.77	-0.72	0.72	0.79	0.53	0.72
Property Plant And Equipment Net	0.94	0.95	0.9	0.77	0.94	0.91	-0.93	0.8		0.29	0.71	-0.65	0.95	0.77	0.89	0.92	0.7	0.77	0.77	0.8	0.95	-0.9	0.91	0.78	0.67	0.91
Current Deferred Revenue	0.51	0.24	0.4	-0.03	0.23	0.03	-0.12	0.15	0.29		0.72	0.13	0.06	-0.18	0.45	0.36	0.3	0.33	-0.18	0.24	0.27	0.05	0.04	0.37	0.49	-0.02
Net Debt	0.83	0.74	0.86	0.62	0.67	0.56	-0.58	0.67	0.71	0.72		-0.24	0.57	0.31	0.9	0.83	0.74	0.87	0.31	0.61	0.74	-0.48	0.53	0.83	0.84	0.49
Retained Earnings	-0.58	-0.66	-0.66	-0.65	-0.68	-0.6	0.72	-0.25	-0.65	0.13	-0.24		-0.74	-0.92	-0.45	-0.58	-0.14	-0.58	-0.92	-0.64	-0.75	0.79	-0.75	-0.47	-0.5	-0.77
Accounts Payable	0.87	0.96	0.86	0.86	0.97	0.97	-0.97	0.78	0.95	0.06	0.57	-0.74		0.87	0.85	0.9	0.65	0.75	0.87	0.86	0.94	-0.98	0.97	0.74	0.59	0.98
Cash	0.69	0.81	0.75	0.79	0.77	0.79	-0.79	0.51	0.77	-0.18	0.31	-0.92	0.87		0.6	0.7	0.37	0.66	1.0	0.79	0.84	-0.93	0.87	0.61	0.57	0.92
Non Current Assets Total	0.93	0.95	0.94	0.84	0.89	0.86	-0.82	0.84	0.89	0.45	0.9	-0.45	0.85	0.6		0.97	0.83	0.91	0.6	0.83	0.91	-0.79	0.81	0.88	0.8	0.8
Non Currrent Assets Other	0.94	0.97	0.95	0.87	0.92	0.9	-0.86	0.77	0.92	0.36	0.83	-0.58	0.9	0.7	0.97		0.77	0.89	0.7	0.82	0.93	-0.86	0.88	0.83	0.79	0.87
Other Assets	0.67	0.74	0.71	0.77	0.68	0.77	-0.65	0.84	0.7	0.3	0.74	-0.14	0.65	0.37	0.83	0.77		0.71	0.37	0.68	0.65	-0.59	0.7	0.87	0.48	0.65
Long Term Debt	0.83	0.87	0.96	0.87	0.78	0.72	-0.72	0.72	0.77	0.33	0.87	-0.58	0.75	0.66	0.91	0.89	0.71		0.66	0.77	0.9	-0.73	0.73	0.9	0.89	0.72
Cash And Short Term Investments	0.69	0.81	0.75	0.79	0.77	0.79	-0.79	0.51	0.77	-0.18	0.31	-0.92	0.87	1.0	0.6	0.7	0.37	0.66		0.79	0.84	-0.93	0.87	0.61	0.57	0.92
Net Receivables	0.83	0.9	0.85	0.83	0.88	0.86	-0.84	0.71	0.8	0.24	0.61	-0.64	0.86	0.79	0.83	0.82	0.68	0.77	0.79		0.89	-0.86	0.88	0.84	0.64	0.88
Good Will	0.94	0.97	0.97	0.86	0.95	0.88	-0.92	0.77	0.95	0.27	0.74	-0.75	0.94	0.84	0.91	0.93	0.65	0.9	0.84	0.89		-0.92	0.91	0.85	0.78	0.91
Common Stock Total Equity	-0.82	-0.94	-0.83	-0.87	-0.92	-0.95	0.91	-0.72	-0.9	0.05	-0.48	0.79	-0.98	-0.93	-0.79	-0.86	-0.59	-0.73	-0.93	-0.86	-0.92		-0.96	-0.7	-0.6	-0.99
Short Term Investments	0.82	0.93	0.84	0.9	0.93	0.96	-0.95	0.72	0.91	0.04	0.53	-0.75	0.97	0.87	0.81	0.88	0.7	0.73	0.87	0.88	0.91	-0.96		0.78	0.54	0.99
Long Term Debt Total	0.81	0.84	0.9	0.84	0.77	0.76	-0.74	0.79	0.78	0.37	0.83	-0.47	0.74	0.61	0.88	0.83	0.87	0.9	0.61	0.84	0.85	-0.7	0.78		0.74	0.74
Non Current Liabilities Total	0.83	0.75	0.89	0.63	0.6	0.53	-0.49	0.53	0.67	0.49	0.84	-0.5	0.59	0.57	0.8	0.79	0.48	0.89	0.57	0.64	0.78	-0.6	0.54	0.74		0.57
Capital Surpluse	0.82	0.94	0.84	0.89	0.92	0.97	-0.92	0.72	0.91	-0.02	0.49	-0.77	0.98	0.92	0.8	0.87	0.65	0.72	0.92	0.88	0.91	-0.99	0.99	0.74	0.57

Click cells to compare fundamentals

Cushman Wakefield Account Relationship Matchups

Cushman Wakefield fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	224.5M	220.8M	226.5M	228M	226.9M	224.9M
Total Assets	7.2B	7.3B	7.9B	7.9B	7.8B	7.7B
Short Long Term Debt Total	3.1B	3.7B	3.7B	3.6B	3.6B	3.5B
Other Current Liab	189.6M	926.3M	1.2B	1.1B	1.1B	786.4M
Total Current Liabilities	2.3B	2.1B	2.4B	2.4B	2.4B	2.4B
Total Stockholder Equity	1.3B	1.1B	1.4B	1.7B	1.7B	1.3B
Other Liab	364.4M	535.5M	392.2M	339.8M	305.8M	399.2M
Net Tangible Assets	(1.7B)	(2.0B)	(1.6B)	786.8M	904.8M	950.1M
Property Plant And Equipment Net	490.7M	438.2M	413.5M	530.6M	502.8M	445.4M
Current Deferred Revenue	948.4M	765.6M	1.1B	872.2M	1.0B	851.0M
Net Debt	2.3B	2.6B	2.9B	3.0B	2.8B	2.8B
Retained Earnings	(1.3B)	(1.5B)	(1.3B)	(1.1B)	(1.1B)	(1.2B)
Accounts Payable	1.1B	1.1B	1.1B	1.2B	1.2B	1.1B
Cash	813.2M	1.1B	770.7M	644.5M	767.7M	791.2M
Non Current Assets Total	4.3B	4.4B	5.1B	5.2B	5.0B	4.9B
Non Currrent Assets Other	685.7M	743.5M	935.7M	976M	805.8M	754.3M
Other Assets	453.6M	569M	806.6M	1.0B	1.2B	693.8M
Long Term Debt	2.6B	3.2B	3.2B	3.2B	3.1B	3.2B
Cash And Short Term Investments	813.2M	1.1B	770.7M	644.5M	767.7M	791.2M
Net Receivables	1.6B	1.6B	1.8B	1.5B	1.8B	1.7B
Good Will	2.0B	2.1B	2.1B	2.1B	2.1B	2.1B
Common Stock Total Equity	22M	22.2M	22.4M	22.6M	20.3M	19.3M
Long Term Debt Total	2.6B	3.2B	3.2B	3.2B	3.7B	3.2B
Liabilities And Stockholders Equity	7.2B	7.3B	7.9B	7.9B	7.8B	7.7B
Non Current Liabilities Total	3.5B	4.2B	4.0B	3.9B	3.7B	4.0B
Capital Surpluse	2.8B	2.8B	2.9B	2.9B	3.3B	2.3B
Other Current Assets	484.4M	223.2M	264.7M	778.1M	151.5M	143.9M
Other Stockholder Equity	4.1B	2.8B	2.9B	2.9B	3.0B	2.6B
Total Liab	5.9B	6.2B	6.4B	6.3B	6.1B	6.4B
Short Long Term Debt	39.3M	39.7M	42.4M	49.8M	149.7M	157.2M
Total Current Assets	2.9B	2.9B	2.8B	2.8B	2.8B	2.8B
Accumulated Other Comprehensive Income	(242.8M)	(242.7M)	(193M)	(191M)	(185.4M)	(194.7M)
Non Current Liabilities Other	352.1M	838.9M	738.1M	293.3M	268.6M	368.5M
Cash And Equivalents	813.2M	1.1B	770.7M	644.5M	741.2M	783.6M
Short Term Debt	39.3M	39.7M	42.4M	49.8M	149.7M	157.2M
Intangible Assets	1.1B	991.2M	922.2M	874.5M	805.9M	850.8M
Common Stock	22M	22.2M	22.4M	22.6M	22.7M	21.6M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Cushman Wakefield plc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cushman Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cushman Wakefield Plc Stock. Highlighted below are key reports to facilitate an investment decision about Cushman Wakefield Plc Stock:

How To Invest In Cushman

Details

Is Cushman Stock a good investment?

Details

What is Cushman Wakefield's Net Worth?

Details

Largest Real Estate Management & Development Companies

View

Largest Real Estate Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cushman Wakefield plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Is Real Estate Management & Development space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cushman Wakefield. If investors know Cushman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cushman Wakefield listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.948

Earnings Share

0.38

Revenue Per Share

41.049

Quarterly Revenue Growth

0.025

Return On Assets

0.0279

The market value of Cushman Wakefield plc is measured differently than its book value, which is the value of Cushman that is recorded on the company's balance sheet. Investors also form their own opinion of Cushman Wakefield's value that differs from its market value or its book value, called intrinsic value, which is Cushman Wakefield's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cushman Wakefield's market value can be influenced by many factors that don't directly affect Cushman Wakefield's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cushman Wakefield's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cushman Wakefield is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cushman Wakefield's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cushman Investments vs Sale Purchase Of Stock Analysis

Investments vs Sale Purchase Of Stock

Investments vs Sale Purchase Of Stock Correlation Analysis

Correlation Coefficient

Investments

Sale Purchase Of Stock

Cushman Wakefield fundamental ratios Correlations

Cushman Wakefield Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cushman Wakefield fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Capital Surpluse	+ 0.99	Short Term Investments
Capital Surpluse	+ 0.98	Accounts Payable
Non Currrent Assets Other	+ 0.97	Total Assets
Good Will	+ 0.97	Total Assets
Good Will	+ 0.97	Short Long Term Debt Total

Capital Surpluse	- 0.99	Common Stock Total Equity
Common Stock Total Equity	- 0.98	Accounts Payable
Other Liab	- 0.98	Total Current Liabilities
Accounts Payable	- 0.97	Other Liab
Short Term Investments	- 0.96	Common Stock Total Equity
Short Term Investments	- 0.95	Other Liab